Does Rallies show 13F holders for GRFS?

Yes. Rallies tracks hedge fund and 13F ownership data for GRFS, including fund names, share counts, latest tracked quarter, and position changes when available.

Is GRFS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GRFS. It does not provide personalized investment advice.

GRFS (Grifois, S.A.) Stock Analysis - Hedge Fund Holdings

Grifois, S.A. (GRFS) is a publicly traded Healthcare sector company. As of May 21, 2026, GRFS trades at $8.20 with a market cap of $5.36B and a P/E ratio of 0.00. GRFS moved +4.46% today. Year to date, GRFS is -12.12%; over the trailing twelve months it is +1.87%. Its 52-week range spans $6.19 to $11.14. Rallies surfaces GRFS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns GRFS stock?

Hedge funds tracked by Rallies that own GRFS include Harris Associates, Soros Fund, Eisler Capital, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Grifois, S.A..

GRFS Key Metrics

Key financial metrics for GRFS
Metric	Value
Price	$8.20
Market Cap	$5.36B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.16%
52-Week High	$11.14
52-Week Low	$6.19
Volume	14
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding GRFS

Harris Associates holds 1.82M shares of GRFS, changed -32.26% as of Mar 31, 2026.
Soros Fund holds 376.00K shares of GRFS, changed -50.00% as of Sep 30, 2024.
Eisler Capital holds 112.70K shares of GRFS, changed +0.00% as of Sep 30, 2024.
Farallon Capital holds 28.00K shares of GRFS, changed +0.00% as of Mar 31, 2026.

Latest GRFS News

Grifols drops as Q1 profit rises, dividend plan and guidance reiterated — May 7, 2026
Grifols jumps as Q1 2026 earnings hit and U.S. plasma optimization stays in focus — Apr 30, 2026
Grifols slides as Health Canada conditions raise scrutiny on Canadian plasma centers — Apr 23, 2026
Grifols slides as U.S. Biopharma IPO plan revives valuation and deleveraging worries — Apr 20, 2026
Grifols jumps after closing €4.7B refinancing that pushes out 2027 maturities — Apr 14, 2026

GRFS Analyst Consensus

GRFS analyst coverage data. Average price target: $0.00.

Common questions about GRFS

Who owns GRFS stock?: Hedge funds tracked by Rallies that own GRFS include Harris Associates, Soros Fund, Eisler Capital, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Grifois, S.A..
Does Rallies show 13F holders for GRFS?: Yes. Rallies tracks hedge fund and 13F ownership data for GRFS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is GRFS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GRFS. It does not provide personalized investment advice.